ProSomnus Sleep Technologies is dedicated to helping dentists treat the growing number of patients with Obstructive Sleep Apnea.
San Francisco, CA, September 14, 2017 – Today – ProSomnus Sleep Technologies announced special hurricane relief
services for any dental sleep practice that has been adversely impacted by Hurricanes Harvey or Irma. These special
- Free of charge shipping on outbound cases
- Net 60 terms on outstanding and future invoices
- Preferred production turnaround time
These services are designed to help dental sleep practices get back on schedule and manage cash flow during the recovery period. Services will extend to the end of October 2017.
“We are grateful that many of the dentists we know in hurricane zones are safe,” stated Len Liptak, CEO of
ProSomnus Sleep Technologies. “We want to do what we can to help their dental sleep practices recover and get back
to treating patients.”
“At times like this, it is imperative that we all step up and work together to help those affected by natural disasters like
this. ProSomnus wants to make it easier for our customers and friends get back into the groove as soon as possible.
Our hearts and prayers are with you all,” Jerry Vogel, VP of Sales for ProSomnus Sleep technologies.
Any dentist interested in taking advantage of these special programs can simply call Michelle Bryant, Account
Manager, directly at 925.557.1348 or via the main service line 844.537.5337. Additionally, you may reach out to your
local representative for further information.
About ProSomnus Sleep Technologies
ProSomnus® Sleep Technologies designs, manufactures and markets highly customizable precision intraoral medical
devices that dentists use to treat patients diagnosed with Obstructive Sleep Apnea. The company’s flagship products
are the ProSomnus® [IA] and ProSomnus MicrO2® Sleep and Snore Devices. They are FDA Cleared Class II Medical
Devices that are smaller, stronger, more biocompatible, and more precise than predicate intraoral sleep apnea devices,
allowing dentists to get patients into therapy faster, and with greater comfort and convenience. They have been used to
treat thousands of patients, with a clinical performance that has been validated in randomized controlled trials,
retrospective cohort studies, and numerous clinical case reports.
Heather Whalen, Senior Director, Marketing and Education